Andreea Anda Alexa

Dr. Andreea Anda Alexa


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 December 2024 in Molecules
Verified
Journal Article
Open access
PDF file
DDDiana Ionela Dăescu
Diana Ionela Dăescu
IPIulia Păușescu
Iulia Păușescu
IBIoana Cristina Benea
Ioana Cristina Benea
Francisc PéterFrancisc Péter
Francisc Péter
ATAnamaria Todea
Anamaria Todea
RBRamona Alina Buzatu
Ramona Alina Buzatu
Given the natural origins of flavylium derivatives, their chemical modifications, and their large potential uses in food, medicine, or green chemistry, the present review is a comprehensive study of flavylium-derived compounds. Several topics such as the green extraction and isolation techniques of flavylium derivatives including their chemical modifications and various characterization tools such as NMR, HPLC, and mass spectrometry are discussed in the review. Furthermore, the use of these derivatives in medicine, food, and materials science is presented, highlighting their relevance and the need for further investigation. Therefore, by examining the advantages and disadvantages of natural and synthetic sources, the review asserts the increased relevance of flavylium-based compounds in active molecules.

16 July 2024 in Applied Sciences
Verified
Journal Article
Open access
PDF file
AAAndreea Anda Alexa
Andreea Anda Alexa
BNBercean V Vasile Nicolae
Bercean V Vasile Nicolae
SBSabina Elena Boncea
Sabina Elena Boncea
Adriana LedetiAdriana Ledeti
Adriana Ledeti
VBValentin Badea
Valentin Badea
Ionut LedetiIonut Ledeti
Ionut Ledeti
In this paper, we present the synthesis, characterization and evaluation of antiproliferative activity for four compounds carrying the 4-amino-5-mercapto-1,2,4-triazol-3-yl scaffold. The synthesis of 1,n-bis-(4-amino-5-mercapto-1,2,4-triazol-3-yl) alkanes was carried out using as starting reagents the dihydrazides of oxalic, malonic, succinic and adipic acids, using mercaptoacetic acid dianion as a leaving group, by a one-pot synthesis method implemented in our research group for the synthesis of 3-substituted-5-mercapto-1,2,4-triazoles. The compounds were obtained with modest yields (12–60%) but with good purity and were characterized by elemental analysis, FTIR, 1H-NMR and 13C-NMR spectroscopy. Also, the stability of the synthesized bis-triazoles was investigated under controlled thermal stress in a dynamic oxidative atmosphere. The last part of the study consisted of biological activity evaluation, by evaluating the antiproliferative activity against the A375 line (human malignant melanoma), as well as on viability of the BJ fibroblast cell line, using MTT and LDH assays.

14 August 2026 in Diagnostics
Verified
Journal Article
Open access
PDF file
DADragomir Ana-Cristiane
Dragomir Ana-Cristiane
RBRamona Alina Buzatu
Ramona Alina Buzatu
RMRuxandra-Cristina Marin
Ruxandra-Cristina Marin
RMRadu Dumitru Moleriu
Radu Dumitru Moleriu
Muntean CalinMuntean Calin
Muntean Calin
MDMarilena Dinuți
Marilena Dinuți
Background/Objectives: Current menopause assessment instruments primarily evaluate vasomotor, somatic, and urogenital symptoms, with limited attention to oral, sensory, and integrated psychological domains. Evidence that oral tissues are estrogen-responsive suggests that oral symptoms may represent an important but underrecognized component of menopausal burden. This study aimed to develop and provide initial psychometric validation of the Multidimensional Menopausal Burden Questionnaire (MMBQ-44), a 44-item instrument integrating systemic, oral, and psychological symptoms. Methods: A cross-sectional validation study was conducted in 308 women aged 45–65 years (perimenopausal n = 66, menopausal n = 40, postmenopausal n = 202). The MMBQ-44 combined items from the Menopause Rating Scale (MRS), Xerostomia Inventory (XI), Oral Health Impact Profile-14 (OHIP-14), and psychological measures derived from the PHQ-9, GAD-7, and HADS. Instrument development included expert review, cognitive interviewing, and field testing. Psychometric evaluation assessed item performance, internal consistency, factor structure, discriminant validity, and known-groups validity. Exploratory factor analysis used principal axis factoring with promax rotation, with factor retention determined by parallel analysis. Results: Internal consistency was good to excellent across domains (Cronbach’s α: 0.813–0.941; McDonald’s ω: 0.864–0.953). All corrected item–total correlations exceeded 0.30. The questionnaire showed strong factorability (KMO = 0.931; Bartlett’s χ2 = 9006.2, p < 0.001). Parallel analysis identified four factors explaining 48.6% of total variance. Psychological and OHIP domains emerged clearly, whereas several MRS and XI items cross-loaded onto related factors. Most HTMT ratios were below 0.85, supporting discriminant validity. Floor effects were observed for OHIP (37.0%) and XI (23.4%). Known-groups validity was modest, with OHIP scores differing significantly across menopausal stages. Conclusions: The MMBQ-44 demonstrates strong reliability and acceptable construct validity as an integrative screening instrument for menopausal burden. Further confirmatory studies and refinement of oral symptom items are warranted.